The Twin Who Froze Time: A 13-Year Botox Experiment Written on Two Identical Faces
Over 13 years, one identical twin received regular Botox to the forehead and brow while her genetically identical sister did not — and the treated twin’s deep, etched-in wrinkles simply never formed. The paper argues that long-term neuromuscular paralysis doesn’t just mask wrinkles temporarily but prevents the permanent “imprinting” of facial lines altogether.
Identical twins are the closest thing biology offers to a controlled experiment on a human face. Same genes, same collagen, same tendency to crease. So when two 38-year-old identical sisters walked into a Los Angeles clinic with dramatically different foreheads, the difference demanded an explanation — and the explanation, according to this report, was Botox.
One twin had received botulinum toxin type A injections into her forehead and frown-line muscles roughly two to three times a year for thirteen years. Her sister had been injected only twice, ever. The result was visible at rest, with no expression at all: the regularly treated twin’s forehead and glabellar (“frown line”) regions were smooth, while her sister carried the fixed, etched horizontal and vertical lines that most people accumulate by midlife.
The core idea is subtle but important. Everyone knows Botox smooths wrinkles while the muscle is chemically frozen. This report argues something further — that by preventing decades of repetitive muscle folding, the skin never develops permanent creases in the first place. These so-called imprinted lines are normally one-way streets: once the dermis and epidermis break down along a fold, no amount of fresh Botox reverses them. You need fillers or laser resurfacing. The twin comparison suggests that starting early and continuing indefinitely may sidestep that damage entirely.
A useful internal control strengthens the picture. Neither twin was treated in the lower face, and both showed comparable nasolabial folds and general aging there. That the divergence appeared only in the treated muscles — and not across the whole face — argues against the simpler explanation that one sister just aged faster.
The caveats are enormous, and the paper is candid about being an observation rather than a trial. This is a single pair of twins, documented photographically, authored by a physician with a direct financial stake in the manufacturer. It proves nothing on its own. But as a proof-of-concept for the “prevention, not just correction” hypothesis, two identical faces telling opposite stories is a striking piece of visual evidence — and one that has shaped cosmetic practice ever since.
Actionable Insights
The practical takeaway is narrow but real: for the specific goal of preventing etched forehead and frown lines, sustained low-frequency treatment appears to work as prophylaxis, not merely cosmetics. The dosing that produced this outcome was modest and stable — roughly 20 to 30 units total across the forehead and 15 to 25 units in the glabella, delivered only two to three times yearly, unchanged across 13 years.
On effect size: this must be stated plainly. No quantitative effect size can be calculated from this paper. There are no measurements, scores, rating scales, or continuous variables — only side-by-side photographs. The “magnitude” is a binary qualitative judgment (lines present versus absent). Any Cohen’s d, relative risk, or hazard ratio would be fabricated. The honest real-world magnitude is: “in one twin pair, imprinted lines were categorically absent in the treated sister.” That is a case observation, not an effect size.
Two secondary practical points survive scrutiny. First, the treated twin’s clinical benefit reportedly held for at least 6 months per session without dose escalation — consistent with prior literature suggesting repeated dosing may lengthen duration. Second, crow’s feet differences appeared only on smiling, not at rest, because that region had been treated for just 2 years — implying the “prevention” effect requires long time horizons, not quick wins.
Context / Source
-
Full title: Long-Term Effects of Botulinum Toxin Type A (Botox) on Facial Lines: A Comparison in Identical Twins
Paper available on Sci-Hub Here: https://sci-hub.st/storage/2024/4123/a175a75273bbf1af4fa648dbfecda1bc/binder2006.pdf - Author / Institution: William J. Binder, MD, Department of Head and Neck Surgery, UCLA School of Medicine, Los Angeles — USA
- Journal: Archives of Facial Plastic Surgery, 2006;8:426-431 (this AMA journal later became JAMA Facial Plastic Surgery; now discontinued)
- Access: Paywalled (AMA/JAMA Network archive)
- Article type: Classified as “Surgical Technique,” but functionally a single case report / twin case study
- Impact Evaluation: The impact score of this journal is approximately 1.5, evaluated against a typical high-end range of 0–60+ for top general science, therefore this is a Low impact journal.
and another similar type of study:
Full paper:
Long-Term Effects of OnabotulinumtoxinA on Facial Lines: A 19-Year Experience of Identical Twins
